Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237445 · ClinicalTrials.gov registry record · Phase 4
Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
A Phase 4 study, sponsored by Sanofi.
- Terminated
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT00237445 is a Phase 4 study that was terminated before completion, run by Sanofi. The registered enrollment target is 110 participants.
The verdict
NCT00237445, a Phase 4 study, was terminated before completion, sponsored by Sanofi.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
A multinational, multicenter, randomized, double-blind, study in areas of high pneumococcal resistance comparing the clinical efficacy and health outcomes of outpatients with mild to moderate Community-Acquired Pneumonia (CAP) treated with either telithromycin once daily for 7 days, or azithromycin once daily for 5 days
Interventions
- DRUG azithromycin
- DRUG telithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00237445
The ClinicalTrials.gov registry entry for NCT00237445 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which azithromycin is the first listed.
NCT00237445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00237445 about?
NCT00237445 is a clinical study titled "Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days". A multinational, multicenter, randomized, double-blind, study in areas of high pneumococcal resistance comparing the clinical efficacy and health outcomes of outpatients with mild to moderate Community-Acquired Pneumonia (CAP) treated with either telithromycin once daily for 7 days, or azithromycin ...
What is the current status of trial NCT00237445?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2005-11. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00237445?
The interventions under investigation include: azithromycin (DRUG), telithromycin (DRUG).
Who is sponsoring clinical trial NCT00237445?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.